eBooks
eBooks are electronic books that offer a convenient and accessible way to access a vast amount of information in digital format. In the field of chemistry and related sciences, eBooks provide valuable resources for research, study, and professional development. At CymitQuimica, we offer a wide selection of eBooks covering a variety of topics, including organic chemistry, inorganic chemistry, chemical analysis, pharmacology, and much more. Among them, you can find subscriptions to digital versions of the most important pharmacopoeias, such as the USP (United States Pharmacopoeia), EP (European Pharmacopoeia), and BP (British Pharmacopoeia). These digital resources are designed to facilitate quick access to updated, high-quality information, supporting researchers, students, and professionals in their projects and studies. Our eBook catalog is carefully selected to provide relevant and useful content, ensuring that our customers always have the necessary tools for success in their respective fields.
Found 35 products of "eBooks"
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Combistats licence
<p>CombiStats is a calculation program for the statistical analysis of data from biological dilution assays according to Ph. Eur. general chapter 5.3.</p>Ref: 41-COMBI003
licence800.00€European Pharmacopoeia 12th Edition-Online only format. Bilingual
<p>EUROPEAN PHARMACOPOEIA 12th EDITION<br> <br>European Pharmacopoeia - Individual licence - Bilingual<br><br>As from the 12th Edition:<br>The European Pharmacopoeia is moving to an online-only format.<br>New publication cycle: each edition will comprise three issues published over a 12 month period (e.g. 12,1, 12,2, 12.3)<br>New 365-days licences (from the activation day of the licence key) with an access to all texts (current, future and archives).<br><br>This licence will grant access to all texts (past, current and future) for 365 days from the activation date.<br><br>Note: for orders placed in May and June 2025, licence keys (EPID) will be sent in July (at the latest).<br><br>Languages: bilingual (English & French).<br><br>ISBN: 978-92-871-9611-8<br><br>The former three-year cycle comprising one edition and eight supplements will be replaced by an annual edition made up of three issues, numbered .1 to .3 (for example, the 12th Edition will consist of Issues 12.1, 12.2 and 12.3). Each of these issues will contain the new and revised texts adopted at one of the three European Pharmacopoeia Commission (EPC) sessions held annually. What will not change is the implementation schedule, which remains January, April and July, respectively, of the year following publication of a text. A detailed calendar presenting the EPC sessions and adoption and implementation dates will be published in due time.<br><br>All subscriptions to the 11th Edition will remain valid during the transitional period until the end of 2025. As of 1 January 2026, users will only be able to subscribe to the online version. </p>Ref: 41-PUB200528
1u650.00€European Pharmacopoeia 11th Edition (11.6-11.7-11.8) - Online Version - Bilingual
<p>European Pharmacopoeia 2025 subscription:<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 11th Edition of the Ph. Eur. was released in July 2024 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8). <br><br>Main volume 11.6 published in July 2024,<br>Supplement 11.7 published in October 2024,<br>Supplement 11.8 published in January 2025.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>Ref: 41-PUB200454
1u570.00€The British Pharmacopoeia 2026 - Single-user online licence
<p>BP 2026- Online Version.<br><br>Single-user access to the BP 2026 online for one named user. Access expires on 31 March 2027.*<br><br>Available from 1 August 2025 | Effective from 1 January 2026 | Superseding the BP 2026.<br><br>New for the BP 2026 edition:<br><br>19 new BP monographs and 34 new monographs reproduced from the 11th edition of the Ph. Eur., as amended by issues 11.6 to 11.8<br><br>Two new appendices, four supplementary chapters, and six new infrared reference spectra have been added to the collection.<br><br>12 new BPCRS have been produced and referenced<br><br>131 amended BP monographs<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. issues up to 11.8<br><br>The Ph. Eur. 12th edition, comprising issues 12.1, 12.2 and 12.3, included as an in-year online and download update<br></p>The British Pharmacopoeia 2025- Hard Copy-printed
<p>BP 2025<br>Available from 1 August 2024 | Effective from 1 January 2025 | Superseding the BP 2025.<br><br> BP 2025 supersedes the BP 2024 and becomes legally effective on 1 January 2025. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>14 new BP monographs, 32 new Ph. Eur. monographs.<br><br>105 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.3 and 11.5.<br><br>Ph. Eur. supplements 11.6 to 11.8 included as in-year online and download product updates.<br></p>The British Pharmacopoeia 2025- Single-user download
<p>BP 2025 single-user download<br><br>Available from 1 August 2024 | Effective from 1 January 2025 | Superseding the BP 2025.<br><br> BP 2025 supersedes the BP 2024 and becomes legally effective on 1 January 2025. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>14 new BP monographs, 32 new Ph. Eur. monographs.<br><br>105 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.3 and 11.5.<br><br>Ph. Eur. supplements 11.6 to 11.8 included as in-year online and download product updates.<br></p>The British Pharmacopoeia 2025 - Package: Six-volume printed edition, including the BP (Veterinary) 2025 - Single user online licence- Single user download for offline use
<p>The BP 2025 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2024<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2025<br>Available from 1 August 2024 | Effective from 1 January 2025 | Superseding the BP 2025.<br><br> BP 2025 supersedes the BP 2024 and becomes legally effective on 1 January 2025. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>14 new BP monographs, 32 new Ph. Eur. monographs.<br><br>105 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.3 and 11.5.<br><br>Ph. Eur. supplements 11.6 to 11.8 included as in-year online and download product updates.<br><br>The BP 2025 package<br>The complete package is a great value-for-money option including:<br><br>A six-volume printed edition, including the BP (Veterinary) 2025<br><br>A single-user online licence*<br><br>A single-user download for offline use*<br><br>Other formats are available to ensure users get the best value access to the information they need.<br><br>Add the BP Archive option to the standard package and receive online access to all the BP editions from 2014 to date.<br><br>Online users can also choose to add the British Approved Names (BAN) 2023 to their package, gaining easy access to this useful reference source of medicinal substance names.</p>The British Pharmacopoeia 2025 - Single-user online licence
<p>BP 2025 single-user online licence.<br>Single named user online access to the BP online. <br>Personal access to the British Pharmacopoeia (BP) 2025 online for one named user. Access will expire on the 31st March 2026<br><br>BP 2024<br>Available from 1 August 2024 | Effective from 1 January 2025 | Superseding the BP 2024<br><br>BP 2025 supersedes the BP 2024 and becomes legally effective on 1 January 2025. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>Monographs and content:<br>14 new BP monographs, 32 new Ph. Eur. monographs.<br>105 amended BP monographs.<br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.5.<br>Ph. Eur. supplements 11.6 to 11.8 included as in-year online and download product updates.<br></p>The British Pharmacopoeia 2025 - Package: Six-volume printed edition, including the BP 2025 - Single user online licence- Single user download for offline use
<p>The BP 2024 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2023<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2024<br>Available from 1 August 2023 | Effective from 1 January 2024 | Superseding the BP 2023.<br><br> BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>27 new BP monographs, 17 new Ph. Eur. monographs.<br><br>93 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.<br><br>Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.<br><br>The BP 2024 package<br>The complete package is a great value-for-money option including:<br><br>A six-volume printed edition, including the BP (Veterinary) 2023<br><br>A single-user online licence*<br><br>A single-user download for offline use*<br><br>Other formats are available to ensure users get the best value access to the information they need.<br><br>Add the BP Archive option to the standard package and receive online access to all the BP editions from 2014 to date.<br><br>Online users can also choose to add the British Approved Names (BAN) 2023 to their package, gaining easy access to this useful reference source of medicinal substance names.</p>The British Pharmacopoeia 2026- Download
<p>BP 2026<br>Available from 1 August 2025 | Effective from 1 January 2026 | Superseding the BP 2026.<br><br><br>New for the BP 2026 edition:<br><br>19 new BP monographs and 34 new monographs reproduced from the 11th edition of the Ph. Eur., as amended by issues 11.6 to 11.8<br><br>Two new appendices, four supplementary chapters, and six new infrared reference spectra have been added to the collection.<br><br>12 new BPCRS have been produced and referenced<br><br>131 amended BP monographs<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. issues up to 11.8<br><br>The Ph. Eur. 12th edition, comprising issues 12.1, 12.2 and 12.3, included as an in-year online and download update<br></p>The British Pharmacopoeia 2023 - Package: Six-volume printed edition, including the BP (Veterinary) 2023 - Single user online licence- Single user download for offline use
<p>The BP 2023 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2023<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2023<br>Available from 1 August 2022 | Effective from 1 January 2023 | Superseding the BP 2022.<br><br>The British Pharmacopoeia (BP) 2021 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.<br><br><br>Why use the BP?<br><br>If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.<br><br>The BP is a vital reference tool for all individuals and organisations involved in pharmaceutical:<br><br> • research<br> • development<br> • manufacture<br> • quality control and analysis<br><br>What does the BP contain?<br><br>The BP includes:<br><br> • general notices (providing general information applicable to all texts)<br> • general monographs (apply to all dosage forms)<br> • specific monographs providing mandatory standards for:<br> • active pharmaceutical ingredients<br> • excipients<br> • formulated preparations (licensed and unlicensed products)<br> • herbal drugs, herbal drug products and herbal medicinal products<br> • materials for use in the manufacture of homoeopathic preparations<br> • blood-related products<br> • immunological products<br> • radiopharmaceutical preparations<br> • infrared reference spectra<br> • appendices<br> • supplementary chapters (providing additional guidance)<br> • comprehensive index<br><br><br>British Pharmacopoeia (Veterinary)<br><br>The BP (Veterinary) is published as a companion volume to the British Pharmacopoeia. It contains standards for substances and products used solely in the practice of veterinary medicine in the UK.<br><br>The BP (Vet) also incorporates monographs and texts of the European Pharmacopoeia.<br><br><br>European Pharmacopoeia<br><br>The Ph. Eur. is published by the European Directorate for the Quality of Medicines & HealthCare.<br><br>The European Pharmacopoeia Commission is responsible for the publication of the Ph. Eur. The UK is a member of the EP Commission and is involved at all stages of Ph. Eur. monograph development.<br><br><br>What's included?<br><br>In addition to all European Pharmacopoeia and BP Veterinary texts being included, the new BP 2023 edition also features:<br><br>Monographs and BPCRS:<br><br>23 new BP monographs, 59 new Ph. Eur. monographs.<br>151 amended BP monographs.<br>All monographs from the Ph. Eur. 10th edition as amended by supplements 10.1 to 10.8 are included.<br>The Ph. Eur. 11th edition, as amended by supplements 11.1 and 11.2 are included as in-year online and download product updates.<br>Updates to BPCRS coincide with BP 2023 to ensure that you remain compliant.<br>Supporting content:<br><br>New Analytical Quality by Design (AQbD) guidance for selected monographs ensures patient safety by providing an outline of best practices to ensure product quality is upheld throughout the product’s lifecycle.<br>The Advanced Therapy Medicinal Products (ATMP) Flow Cytometry and Vector Copy Number best practice guidance texts offer a practical and phase appropriate validation tool to help your cell therapy programme succeed.<br>A new Supplementary Chapter for Inactivated Veterinary Autogenous Vaccines.<br>Online tools and guides: <br><br>Revision History allows website users to easily view and understand the reasons a change to a monograph has been made.<br>Tracked Changes makes it easier for you to see where we have made changes, so you can only the most recent and relevant monographs.<br>Concise ’How to use the BP’ guide helps you become more familiar with the requirements of the BP, where to locate the different types of information and how to apply a formulated preparation monograph.</p>The British Pharmacopoeia 2021 - Single-user online licence
<p>BP 2021 single-user online licence.<br>Single named user online access to the BP online. <br><br><br>BP 2021<br>Available from 1 August 2020 | Effective from 1 January 2021 | Superseding the BP 2020<br><br>The British Pharmacopoeia (BP) 2021 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.<br><br><br>Why use the BP?<br><br>If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.<br><br>The BP is a vital reference tool for all individuals and organisations involved in pharmaceutical:<br><br> • research<br> • development<br> • manufacture<br> • quality control and analysis<br><br>What does the BP contain?<br><br>The BP includes:<br><br> • general notices (providing general information applicable to all texts)<br> • general monographs (apply to all dosage forms)<br> • specific monographs providing mandatory standards for:<br> • active pharmaceutical ingredients<br> • excipients<br> • formulated preparations (licensed and unlicensed products)<br> • herbal drugs, herbal drug products and herbal medicinal products<br> • materials for use in the manufacture of homoeopathic preparations<br> • blood-related products<br> • immunological products<br> • radiopharmaceutical preparations<br> • infrared reference spectra<br> • appendices<br> • supplementary chapters (providing additional guidance)<br> • comprehensive index<br><br><br>British Pharmacopoeia (Veterinary)<br><br>The BP (Veterinary) is published as a companion volume to the British Pharmacopoeia. It contains standards for substances and products used solely in the practice of veterinary medicine in the UK.<br><br>The BP (Vet) also incorporates monographs and texts of the European Pharmacopoeia.<br><br><br>European Pharmacopoeia<br><br>The Ph. Eur. is published by the European Directorate for the Quality of Medicines & HealthCare.<br><br>The European Pharmacopoeia Commission is responsible for the publication of the Ph. Eur. The UK is a member of the EP Commission and is involved at all stages of Ph. Eur. monograph development.<br><br><br>What's included?<br><br>In addition to all European Pharmacopoeia texts being included, the new edition also features:<br><br> • 30 new BP monographs, 20 new Ph. Eur. monographs.<br> • 171 amended BP monographs.<br> • All monographs from the Ph. Eur. 10th edition and supplements 10.1 and 10.2 are included.<br> • Ph. Eur. supplements 10.3, 10.4, and 10.5 included as in-year online and download product updates.<br> • New Tracked Changes functionality makes it easier to identify changes made to monographs and view the most recent versions suitable to you. Save time when reading through monographs with clear symbols highlighting different types of changes and customise your view by toggling through different levels of detail.<br> • Streamlined Timeline functionality and cleaner design helps you find the information you need. Easily see the editions of the BP in which a monograph was published and subsequently revised. Archive subscribers can now access all previous editions of BP and Ph. Eur., through the improved navigation.<br> • Concise ‘How to use the BP’ guide helps you to comply with the BP, navigate more effectively and follow formulated product monographs.<br> • We're releasing 8 new BPCRS to coincide with the new and revised monographs in the BP 2021. This means you can order the new chemical reference standards alongside the BP 2020 - helping you comply with the new standards from January 2021.<br> • Ensure you get the best value access to the information you need. Choose from a range of flexible licences and formats – including full online and offline access.<br><br></p>The British Pharmacopoeia 2024 - Single-user online licence
<p>BP 2024 single-user online licence.<br>Single named user online access to the BP online. <br>Personal access to the British Pharmacopoeia (BP) 2023 online for one named user. Access will expire on the 31st March 2025<br><br>BP 2024<br>Available from 1 August 2023 | Effective from 1 January 2024 | Superseding the BP 2023<br><br>BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>Monographs and content:<br>27 new BP monographs, 17 new Ph. Eur. monographs.<br>93 amended BP monographs.<br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.<br>Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.<br></p>The British Pharmacopoeia 2023- Single-user download
<p>BP 2023 single-user download<br><br>BP 2023<br>Available from 1 August 2022 | Effective from 1 January 2023 | Superseding the BP 2022<br><br>The British Pharmacopoeia (BP) 2023 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.<br><br><br>Why use the BP?<br><br>If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.<br><br>The BP is a vital reference tool for all individuals and organisations involved in pharmaceutical:<br><br> • research<br> • development<br> • manufacture<br> • quality control and analysis<br><br>What does the BP contain?<br><br>The BP includes:<br><br> • general notices (providing general information applicable to all texts)<br> • general monographs (apply to all dosage forms)<br> • specific monographs providing mandatory standards for:<br> • active pharmaceutical ingredients<br> • excipients<br> • formulated preparations (licensed and unlicensed products)<br> • herbal drugs, herbal drug products and herbal medicinal products<br> • materials for use in the manufacture of homoeopathic preparations<br> • blood-related products<br> • immunological products<br> • radiopharmaceutical preparations<br> • infrared reference spectra<br> • appendices<br> • supplementary chapters (providing additional guidance)<br> • comprehensive index<br><br><br>British Pharmacopoeia (Veterinary)<br><br>The BP (Veterinary) is published as a companion volume to the British Pharmacopoeia. It contains standards for substances and products used solely in the practice of veterinary medicine in the UK.<br><br>The BP (Vet) also incorporates monographs and texts of the European Pharmacopoeia.<br><br><br>European Pharmacopoeia<br><br>The Ph. Eur. is published by the European Directorate for the Quality of Medicines & HealthCare.<br><br>The European Pharmacopoeia Commission is responsible for the publication of the Ph. Eur. The UK is a member of the EP Commission and is involved at all stages of Ph. Eur. monograph development.<br><br><br>What's included?<br><br>In addition to all European Pharmacopoeia texts being included, the new edition also features:<br><br>The BP 2023 supersedes the BP 2022 and becomes legally effective on 1 January 2023. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>Monographs and content:<br><br>23 new BP monographs, 59 new Ph. Eur. monographs.<br><br>151 amended BP monographs.<br><br>All monographs from the Ph. Eur. 10th edition as amended by Supplements 10.1 to 10.8 are included.<br><br>Ph. Eur. supplements 11.0, 11.1, and 11.2 included as in-year online and download product updates<br> • New Tracked Changes functionality makes it easier to identify changes made to monographs and view the most recent versions suitable to you. Save time when reading through monographs with clear symbols highlighting different types of changes and customise your view by toggling through different levels of detail.<br> • Streamlined Timeline functionality and cleaner design helps you find the information you need. Easily see the editions of the BP in which a monograph was published and subsequently revised. Archive subscribers can now access all previous editions of BP and Ph. Eur., through the improved navigation.<br> • Concise ‘How to use the BP’ guide helps you to comply with the BP, navigate more effectively and follow formulated product monographs.<br> • We're releasing 8 new BPCRS to coincide with the new and revised monographs in the BP 2021. This means you can order the new chemical reference standards alongside the BP 2020 - helping you comply with the new standards from January 2021.<br> • Ensure you get the best value access to the information you need. Choose from a range of flexible licences and formats – including full online and offline access.<br><br></p>The British Pharmacopoeia 2023 - Single-user online licence
<p>BP 2023 single-user online licence.<br>Single named user online access to the BP online. <br>Personal access to the British Pharmacopoeia (BP) 2023 online for one named user. Access will expire on the 31st March 2024<br><br>BP 2023<br>Available from 1 August 2022 | Effective from 1 January 2023 | Superseding the BP 2022<br><br>The British Pharmacopoeia (BP) 2022 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.<br><br><br>Why use the BP?<br><br>If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.<br><br>The BP is a vital reference tool for all individuals and organisations involved in pharmaceutical:<br><br> • research<br> • development<br> • manufacture<br> • quality control and analysis<br><br>What does the BP contain?<br><br>The BP includes:<br><br> • general notices (providing general information applicable to all texts)<br> • general monographs (apply to all dosage forms)<br> • specific monographs providing mandatory standards for:<br> • active pharmaceutical ingredients<br> • excipients<br> • formulated preparations (licensed and unlicensed products)<br> • herbal drugs, herbal drug products and herbal medicinal products<br> • materials for use in the manufacture of homoeopathic preparations<br> • blood-related products<br> • immunological products<br> • radiopharmaceutical preparations<br> • infrared reference spectra<br> • appendices<br> • supplementary chapters (providing additional guidance)<br> • comprehensive index<br><br><br>British Pharmacopoeia (Veterinary)<br><br>The BP (Veterinary) is published as a companion volume to the British Pharmacopoeia. It contains standards for substances and products used solely in the practice of veterinary medicine in the UK.<br><br>The BP (Vet) also incorporates monographs and texts of the European Pharmacopoeia.<br><br><br>European Pharmacopoeia<br><br>The Ph. Eur. is published by the European Directorate for the Quality of Medicines & HealthCare.<br><br>The European Pharmacopoeia Commission is responsible for the publication of the Ph. Eur. The UK is a member of the EP Commission and is involved at all stages of Ph. Eur. monograph development.<br><br><br>What's included?<br><br>In addition to all European Pharmacopoeia texts being included, the new edition also features:<br><br>23 new BP monographs, 59 new Ph. Eur. monographs.<br>151 amended BP monographs.<br>All monographs from the Ph. Eur. 10th edition as amended by Supplements 10.1 to 10.8 are included.<br>Ph. Eur. supplements 11.0, 11.1, and 11.2 included as in-year online and download product updates.<br><br> • New Tracked Changes functionality makes it easier to identify changes made to monographs and view the most recent versions suitable to you. Save time when reading through monographs with clear symbols highlighting different types of changes and customise your view by toggling through different levels of detail.<br> • Streamlined Timeline functionality and cleaner design helps you find the information you need. Easily see the editions of the BP in which a monograph was published and subsequently revised. Archive subscribers can now access all previous editions of BP and Ph. Eur., through the improved navigation.<br> • Concise ‘How to use the BP’ guide helps you to comply with the BP, navigate more effectively and follow formulated product monographs.<br> • We're releasing 8 new BPCRS to coincide with the new and revised monographs in the BP 2021. This means you can order the new chemical reference standards alongside the BP 2020 - helping you comply with the new standards from January 2021.<br> • Ensure you get the best value access to the information you need. Choose from a range of flexible licences and formats – including full online and offline access.<br><br></p>The British Pharmacopoeia 2021 - Package
<p>The BP 2021 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2020<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2021<br>Available from 1 August 2020 | Effective from 1 January 2021 | Superseding the BP 2020<br><br>The British Pharmacopoeia (BP) 2021 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.<br><br><br>Why use the BP?<br><br>If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.<br><br>The BP is a vital reference tool for all individuals and organisations involved in pharmaceutical:<br><br> • research<br> • development<br> • manufacture<br> • quality control and analysis<br><br>What does the BP contain?<br><br>The BP includes:<br><br> • general notices (providing general information applicable to all texts)<br> • general monographs (apply to all dosage forms)<br> • specific monographs providing mandatory standards for:<br> • active pharmaceutical ingredients<br> • excipients<br> • formulated preparations (licensed and unlicensed products)<br> • herbal drugs, herbal drug products and herbal medicinal products<br> • materials for use in the manufacture of homoeopathic preparations<br> • blood-related products<br> • immunological products<br> • radiopharmaceutical preparations<br> • infrared reference spectra<br> • appendices<br> • supplementary chapters (providing additional guidance)<br> • comprehensive index<br><br><br>British Pharmacopoeia (Veterinary)<br><br>The BP (Veterinary) is published as a companion volume to the British Pharmacopoeia. It contains standards for substances and products used solely in the practice of veterinary medicine in the UK.<br><br>The BP (Vet) also incorporates monographs and texts of the European Pharmacopoeia.<br><br><br>European Pharmacopoeia<br><br>The Ph. Eur. is published by the European Directorate for the Quality of Medicines & HealthCare.<br><br>The European Pharmacopoeia Commission is responsible for the publication of the Ph. Eur. The UK is a member of the EP Commission and is involved at all stages of Ph. Eur. monograph development.<br><br><br>What's included?<br><br>In addition to all European Pharmacopoeia texts being included, the new edition also features:<br><br> • 30 new BP monographs, 20 new Ph. Eur. monographs.<br> • 171 amended BP monographs.<br> • All monographs from the Ph. Eur. 10th edition and supplements 10.1 and 10.2 are included.<br> • Ph. Eur. supplements 10.3, 10.4, and 10.5 included as in-year online and download product updates.<br> • New Tracked Changes functionality makes it easier to identify changes made to monographs and view the most recent versions suitable to you. Save time when reading through monographs with clear symbols highlighting different types of changes and customise your view by toggling through different levels of detail.<br> • Streamlined Timeline functionality and cleaner design helps you find the information you need. Easily see the editions of the BP in which a monograph was published and subsequently revised. Archive subscribers can now access all previous editions of BP and Ph. Eur., through the improved navigation.<br> • Concise ‘How to use the BP’ guide helps you to comply with the BP, navigate more effectively and follow formulated product monographs.<br> • We're releasing 8 new BPCRS to coincide with the new and revised monographs in the BP 2021. This means you can order the new chemical reference standards alongside the BP 2020 - helping you comply with the new standards from January 2021.<br> • Ensure you get the best value access to the information you need. Choose from a range of flexible licences and formats – including full online and offline access.</p>The British Pharmacopoeia 2021 - Single-user download
<p>BP 2021 single-user download<br><br>BP 2021<br>Available from 1 August 2020 | Effective from 1 January 2021 | Superseding the BP 2020<br><br>The British Pharmacopoeia (BP) 2021 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.<br><br><br>Why use the BP?<br><br>If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.<br><br>The BP is a vital reference tool for all individuals and organisations involved in pharmaceutical:<br><br> • research<br> • development<br> • manufacture<br> • quality control and analysis<br><br>What does the BP contain?<br><br>The BP includes:<br><br> • general notices (providing general information applicable to all texts)<br> • general monographs (apply to all dosage forms)<br> • specific monographs providing mandatory standards for:<br> • active pharmaceutical ingredients<br> • excipients<br> • formulated preparations (licensed and unlicensed products)<br> • herbal drugs, herbal drug products and herbal medicinal products<br> • materials for use in the manufacture of homoeopathic preparations<br> • blood-related products<br> • immunological products<br> • radiopharmaceutical preparations<br> • infrared reference spectra<br> • appendices<br> • supplementary chapters (providing additional guidance)<br> • comprehensive index<br><br><br>British Pharmacopoeia (Veterinary)<br><br>The BP (Veterinary) is published as a companion volume to the British Pharmacopoeia. It contains standards for substances and products used solely in the practice of veterinary medicine in the UK.<br><br>The BP (Vet) also incorporates monographs and texts of the European Pharmacopoeia.<br><br><br>European Pharmacopoeia<br><br>The Ph. Eur. is published by the European Directorate for the Quality of Medicines & HealthCare.<br><br>The European Pharmacopoeia Commission is responsible for the publication of the Ph. Eur. The UK is a member of the EP Commission and is involved at all stages of Ph. Eur. monograph development.<br><br><br>What's included?<br><br>In addition to all European Pharmacopoeia texts being included, the new edition also features:<br><br> • 30 new BP monographs, 20 new Ph. Eur. monographs.<br> • 171 amended BP monographs.<br> • All monographs from the Ph. Eur. 10th edition and supplements 10.1 and 10.2 are included.<br> • Ph. Eur. supplements 10.3, 10.4, and 10.5 included as in-year online and download product updates.<br> • New Tracked Changes functionality makes it easier to identify changes made to monographs and view the most recent versions suitable to you. Save time when reading through monographs with clear symbols highlighting different types of changes and customise your view by toggling through different levels of detail.<br> • Streamlined Timeline functionality and cleaner design helps you find the information you need. Easily see the editions of the BP in which a monograph was published and subsequently revised. Archive subscribers can now access all previous editions of BP and Ph. Eur., through the improved navigation.<br> • Concise ‘How to use the BP’ guide helps you to comply with the BP, navigate more effectively and follow formulated product monographs.<br> • We're releasing 8 new BPCRS to coincide with the new and revised monographs in the BP 2021. This means you can order the new chemical reference standards alongside the BP 2020 - helping you comply with the new standards from January 2021.<br> • Ensure you get the best value access to the information you need. Choose from a range of flexible licences and formats – including full online and offline access.<br><br></p>Pharmacopoeia of the People's Republic of China -2020-Print Hardback
<p>The Pharmacopoeia of the People's Republic of China 2020 edition is the 11th edition. It covers both traditional Chinese medicine and Western medicines. It gives descriptions and information of purity, testing, dosage, precautions, storage and strength of each drug.<br><br>The latest edition of Chinese Pharmacopoeia was released on July 2, 2020, and took effect on December 30, 2020. this edition of pharmacopoeia includes 5911 monographs, 319 new additions, 3177 revisions, 10 rejections, and 6 reductions due to the merger of monographs.<br><br>Format: 4 hardback volumes with slipcases	<br>Published: 01 Dec 2022</p>The British Pharmacopoeia 2023- print
<p>BP 2023 print<br><br>BP 2023<br>Available from 1 August 2022 | Effective from 1 January 2023 | Superseding the BP 2022<br><br>The British Pharmacopoeia (BP) 2023 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.<br><br><br>Why use the BP?<br><br>If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.<br><br>The BP is a vital reference tool for all individuals and organisations involved in pharmaceutical:<br><br> • research<br> • development<br> • manufacture<br> • quality control and analysis<br><br>What does the BP contain?<br><br>The BP includes:<br><br> • general notices (providing general information applicable to all texts)<br> • general monographs (apply to all dosage forms)<br> • specific monographs providing mandatory standards for:<br> • active pharmaceutical ingredients<br> • excipients<br> • formulated preparations (licensed and unlicensed products)<br> • herbal drugs, herbal drug products and herbal medicinal products<br> • materials for use in the manufacture of homoeopathic preparations<br> • blood-related products<br> • immunological products<br> • radiopharmaceutical preparations<br> • infrared reference spectra<br> • appendices<br> • supplementary chapters (providing additional guidance)<br> • comprehensive index<br><br><br>British Pharmacopoeia (Veterinary)<br><br>The BP (Veterinary) is published as a companion volume to the British Pharmacopoeia. It contains standards for substances and products used solely in the practice of veterinary medicine in the UK.<br><br>The BP (Vet) also incorporates monographs and texts of the European Pharmacopoeia.<br><br><br>European Pharmacopoeia<br><br>The Ph. Eur. is published by the European Directorate for the Quality of Medicines & HealthCare.<br><br>The European Pharmacopoeia Commission is responsible for the publication of the Ph. Eur. The UK is a member of the EP Commission and is involved at all stages of Ph. Eur. monograph development.<br><br><br>What's included?<br><br>In addition to all European Pharmacopoeia texts being included, the new edition also features:<br><br>The BP 2023 supersedes the BP 2022 and becomes legally effective on 1 January 2023. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>Monographs and content:<br><br>23 new BP monographs, 59 new Ph. Eur. monographs.<br><br>151 amended BP monographs.<br><br>All monographs from the Ph. Eur. 10th edition as amended by Supplements 10.1 to 10.8 are included.<br><br>Ph. Eur. supplements 11.0, 11.1, and 11.2 included as in-year online and download product updates<br> • New Tracked Changes functionality makes it easier to identify changes made to monographs and view the most recent versions suitable to you. Save time when reading through monographs with clear symbols highlighting different types of changes and customise your view by toggling through different levels of detail.<br> • Streamlined Timeline functionality and cleaner design helps you find the information you need. Easily see the editions of the BP in which a monograph was published and subsequently revised. Archive subscribers can now access all previous editions of BP and Ph. Eur., through the improved navigation.<br> • Concise ‘How to use the BP’ guide helps you to comply with the BP, navigate more effectively and follow formulated product monographs.<br> • We're releasing 8 new BPCRS to coincide with the new and revised monographs in the BP 2021. This means you can order the new chemical reference standards alongside the BP 2020 - helping you comply with the new standards from January 2021.<br> • Ensure you get the best value access to the information you need. Choose from a range of flexible licences and formats – including full online and offline access.<br><br></p>The British Pharmacopoeia 2024- Single-user download
<p>BP 2024 single-user download<br><br>BP 2024<br>Available from 1 August 2023 | Effective from 1 January 2024 | Superseding the BP 2023<br><br>The BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>27 new BP monographs, 17 new Ph. Eur. monographs.<br><br>93 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.<br><br>Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates<br><br></p>The British Pharmacopoeia 2024- print
<p>New for the BP 2024<br>The BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January<br>2024. This edition incorporates new monographs from both the BP and Ph. Eur.<br>along with a significant number of revised monographs.<br>■ 27 new BP monographs, 17 new Ph. Eur. monographs.<br>■ 93 amended BP monographs.<br>■ All monographs from the Ph. Eur. 11th edition<br>■ Ph. Eur. supplements 11.4 to 11.6 included as in-year online and download<br>product updates<br>■ We are updating the BP website to improve your experience of using the site.<br>Updated features for the 2024 edition include:<br>» A fresh and user-friendly site design, coupled with improved navigation<br>» Enhanced purchasing journeys for a seamless experience<br>» Enhanced layout allows you to search and find the monographs you need<br>» Advanced in-publication search functionality<br>» A revamped timeline and tracked changes feature, enabling you to track<br>the evolution of monographs over time</p>The British Pharmacopoeia 2024 - Package: Six-volume printed edition, including the BP (Veterinary) 2024 - Single user online licence- Single user download for offline use
<p>The BP 2024 complete package<br><br> • Six-volume printed edition, including the BP (Veterinary) 2023<br> • Single-user online licence<br> • Single-user download for offline use<br><br><br>BP 2024<br>Available from 1 August 2023 | Effective from 1 January 2024 | Superseding the BP 2023.<br><br> BP 2024 supersedes the BP 2023 and becomes legally effective on 1 January 2024. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.<br><br>27 new BP monographs, 17 new Ph. Eur. monographs.<br><br>93 amended BP monographs.<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.<br><br>Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.<br><br>The BP 2024 package<br>The complete package is a great value-for-money option including:<br><br>A six-volume printed edition, including the BP (Veterinary) 2023<br><br>A single-user online licence*<br><br>A single-user download for offline use*<br><br>Other formats are available to ensure users get the best value access to the information they need.<br><br>Add the BP Archive option to the standard package and receive online access to all the BP editions from 2014 to date.<br><br>Online users can also choose to add the British Approved Names (BAN) 2023 to their package, gaining easy access to this useful reference source of medicinal substance names.</p>The British Pharmacopoeia 2026- Hard Copy-printed
<p>BP 2026<br>Available from 1 August 2025 | Effective from 1 January 2026 | Superseding the BP 2026.<br><br><br>New for the BP 2026 edition:<br><br>19 new BP monographs and 34 new monographs reproduced from the 11th edition of the Ph. Eur., as amended by issues 11.6 to 11.8<br><br>Two new appendices, four supplementary chapters, and six new infrared reference spectra have been added to the collection.<br><br>12 new BPCRS have been produced and referenced<br><br>131 amended BP monographs<br><br>All monographs from the Ph. Eur. 11th edition and Ph. Eur. issues up to 11.8<br><br>The Ph. Eur. 12th edition, comprising issues 12.1, 12.2 and 12.3, included as an in-year online and download update<br></p>European Pharmacopoeia 10th Edition (10.0-10.1-10.2) - Electronic Version - Bilingual
<p>Installation of the application to 1 computer and to 1 USB stick, for online or offline use<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 10.0 published in July 2019,<br>Supplement 10.1 published in October 2019,<br>Supplement 10.2 published in January 2020.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>European Pharmacopoeia 10th Edition (10.6-10.7-10.8) - Electronic Version - Bilingual
<p>Online and downloadable access to Supplement 10.6 to Supplement 10.8<br><br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2021 to the end of December 2022.<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Supplement 10.6 published in July 2021,<br>Supplement 10.7 published in October 2021 and<br>Supplement 10.8 published in January 2022.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>European Pharmacopoeia 10th Edition (10.3-10.4-10.5) - Electronic Version - Bilingual
<p>Online and downloadable access to Supplement 10.3 to Supplement 10.5<br><br>Cumulative version.<br>Languages: English, French.<br><br>This will give you access from July 2020 to the end of December 2021.<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 10th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Supplement 10.3 published in July 2020,<br>Supplement 10.4 published in October 2020 and<br>Supplement 10.5 published in January 2021.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>European Pharmacopoeia 11th Edition (11.0-11.1-11.2) - Package (online Version + Book) - English
<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 11th Edition of the Ph. Eur. was released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8). <br><br>Supplement 11.0 published in July 2022,<br>Supplement 11.1 published in October 2022 and<br>Supplement 11.2 published in January 2023.<br><br><br>Print version<br><br>The 11th Edition consists of three initial volumes (11.0) complemented by eight non-cumulative supplements (11.1 to 11.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.<br></p>European Pharmacopoeia 11th Edition (11.0-11.1-11.2) - Online Version - Bilingual
<p>Available to order from July 2022 / Effective from 1 January 2023<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 11.0 published in July 2022,<br>Supplement 11.1 published in October 2022,<br>Supplement 11.2 published in January 2023.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>European Pharmacopoeia 11th Edition (11.3-11.4-11.5) - Package (online Version + Book) - English
<p>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 11th Edition of the Ph. Eur. was released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8). <br>Supplement 11.3 published in July 2023,<br>Supplement 11.4 published in October 2023 and<br>Supplement 11.5 published in January 2024.<br><br><br>Print version<br><br>The 11th Edition consists of three initial volumes (11.0) complemented by eight non-cumulative supplements (11.1 to 11.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapter through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.<br></p>European Pharmacopoeia 11th Edition (11.3-11.4-11.5) - Online Version - Bilingual
<p>2024 subscription to the European Pharmacopoeia<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 11.3 published in July 2023,<br>Supplement 11.4 published in October 2023,<br>Supplement 11.5 published in January 2024.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>


